Imatinib mesylate and Prilosec drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imatinib mesylate (imatinib mesylate) and Prilosec (omeprazole). Common drug interactions include tachycardia among females and abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people have when they take Imatinib mesylate and Prilosec. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Imatinib mesylate?

Imatinib mesylate has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 4,178 Imatinib mesylate users. Check the latest studies of Imatinib mesylate.

What is Prilosec?

Prilosec has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 175,285 Prilosec users. Check the latest studies of Prilosec.

On Jul, 15, 2026

13 people who take Imatinib mesylate and Prilosec together, and have interactions are studied.

Imatinib mesylate and Prilosec drug interactions.

What are the common drug interactions of Imatinib Mesylate and Prilosec, by gender? *:

female:

Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Ventricular dysfunction (heart dysfunction)
Ventricular failure (heart failure)
Ventricular fibrillation (abnormally irregular heart rhythm)
Vomiting
Confusional state
Disease progression
Hemiparesis (weakness on one side of the body)
Neurological symptom (symptoms of nervous system disease)
Petit mal epilepsy (absence seizure)

male:

Abdominal pain upper
Weight decreased
Cardiac failure congestive
Cardiomyopathy (weakening of the heart muscle)
Chest discomfort
Chest pain
Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood)
Constipation
Cough
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the common drug interactions of Imatinib Mesylate and Prilosec, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal discomfort
Aphagia (inability or refusal to swallow)
Death
Drug ineffective
Haematemesis (vomiting of blood)
Oesophageal perforation (hole in oesophagus)
Vomiting
Weight decreased

30-39:

n/a

40-49:

Muscle spasms (muscle contraction)

50-59:

Cardiac failure

60+:

Asthenia (weakness)
Fall
Cardiac failure congestive
Cardiomyopathy (weakening of the heart muscle)
Chest discomfort
Chest pain
Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood)
Constipation
Cough
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 4 people, 30.77%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 23.08%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 15.38%
Neck Pain: 1 person, 7.69%
Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 1 person, 7.69%
Gastrointestinal Carcinoma (cancer of stomach or intestine): 1 person, 7.69%
Gastric Ulcer (stomach ulcer): 1 person, 7.69%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 7.69%
Blood Pressure Abnormal: 1 person, 7.69%
Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Imatinib mesylate and Prilosec?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously